Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The “Experts in Residence” programme is managed by the Translational Research Office, the Business Partnerships Office and Oxford University Innovation. It aims to give Oxford's research community access to world-leading expertise and advice across multiple industry sectors. Scientists can arrange meetings with our experts to discuss their ideas and projects with no strings attached. We expect that this advice and support will help scientists develop the translational strategy for their projects/technologies.

For more information explore these pages, or contact the Translational Research Office to book a meeting with an expert. 

OUR EXPERTS

 Product Design in Biomedical Engineering 

Patrick Hall

Patrick Hall, Managing Director, Designing Science Ltd

 

 

 

 Drug Discovery and development

Thomas Hanke© John Cairns

 

Dr Thomas Hanke, Head of Academic Partnerships at Evotec

 

 

 

Andy Pearce

 

Dr Andy Pearce, Director, Discovery Partnerships with Academia at GSK

 

 

 

Simon J Hollingsworth

 

Professor Simon Hollingsworth, VP, Global Medicine Leader, AstraZeneca

 

 

                                

Rachel Hemsley

Dr Rachel Hemsley, Global Head of Business Development, Xenogesis

 

 

 

 

Colin T Dourish

 

Dr Colin T Dourish, Director and Co-Owner of P1vital and P1vital Products 

 

 

 

 

Anthony Brown

 

Dr Anthony Brown, VP Business Development & Scientific Liaison, Carrick Therapeutics

 

 

 

Digital Health 

 Anonymous profile photo

Dr Steve Gardner, Co-founder and CEO, PrecisionLife

 

 

 

Anonymous profile photo

 

Dr Veronique Bouchet, Chief Medical Officer, PrecisionLife;

 

 

  

Anonymous profile photo

 

Paul O'Donohoe, Scientific Lead, eCOA and Mobile Health, Medidata Solutions;

 

 

 

Bobby Kaura

 

Bobby Kaura, Seed Investment, EMEA Outreach & International Development, Illumina Accelerator

 

 

 

 

Med Tech Regulation 

Toni Day

 

Dr Toni Day, Director of Quality and Regulatory Affairs at OrganOx

 

 

 

Diagnostics

Adam Hill

 

Dr Adam Hill, Ceo of Oncimmune

 

 

 

Clinical Research

Steve McConchiee

 

Dr Steve McConchie, CEO of Aptus

 

 

       

Anonymous profile photoMatthew Reaney, Head of Patient Centered Endpoints, Science & Analytical Teams, IQVIA

 

 

 

 

Innovation

Nicholas Duggan

 

 

Nicholas Duggan, Partner at Viadynamics

 

 

 

 

Joanne Hackett

 

  Dr Joanne Hackett, IZY Capital

 

 

 

 

Laura Ferguson

 

Dr Laura Ferguson, AstraZeneca